HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Quote:
Login Free Membership
Search:

Press Releases  

Zacks Bull and Bear of the Day Highlights: Neurocrine Bio, Interactive Brokers, Hess, Total SA, BP and Royal Dutch Shell

Share
June 23, 2010 | Comment(s): 0
Recommended this article (6)
NBIX | IBKR | HES | TOT | BP | RDS.A

For Immediate Release

Chicago, IL – June 23, 2010 – Zacks Equity Research highlights Neurocrine Bio (NBIX - Analyst Report) as the Bull of the Day and Interactive Brokers Group (IBKR - Analyst Report) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Hess Corporation (HES - Analyst Report), Total SA (TOT - Analyst Report), BP plc (BP - Analyst Report) and Royal Dutch Shell (RDS.A - Analyst Report).

Full analysis of all these stocks is available at http://at.zacks.com/?id=5506.

Here is a synopsis of all five stocks:

Bull of the Day:

Neurocrine Bio (NBIX - Analyst Report) recently entered a deal with Abbott, which paid Neurocrine $75 million upfront, with the potential for another $500 million plus royalties still to come.

The partnership is a homerun in our view. Abbott is the ideal partner for Neurocrine with elagolix. The news comes less than a month after the phase II DAISY-901 program offered up positive data on all primary and secondary endpoints for the treatment of endometriosis.

We expect Abbott to be in position to initiate the phase III program on elagolix in endometriosis by the end of the year.

Bear of the Day:

Interactive Brokers Group's (IBKR - Analyst Report) first quarter 2010 earnings were substantially short of the Zacks Consensus Estimate. Earnings were also down from the prior-year quarter.

The results declined due primarily to competitive pressure on spreads as a result of constrained liquidity and other market challenges. Dwindling equity market volatility in the past quarters continues to negatively impact the results of its Market Making segment.

Though Interactive's fundamentals remain strong with a highly liquid balance sheet, strong capital position and high barriers to entry, significant international exposure and increased market risk could impact profitability in the upcoming quarters. Hence, we are maintaining an Underperform rating on the stock.

Latest Posts on the Zacks Analyst Blog:

Hess Gains Momentum in Norway

The U.S. oil integrated company Hess Corporation (HES - Analyst Report) beefed up its interest in two offshore fields in Norway – Valhall and Hod – by exercising its right to pre-empt Total SA's (TOT - Analyst Report) sale of interests to BP plc (BP - Analyst Report). Hess will assume 7.85% and 12.5% interest in Valhall and Hod fields, respectively, for a total consideration of $496 million. The agreement is subject to regulatory approvals and is expected to be completed by the end of the third quarter of 2010.

The transaction will bring Hess’ interests in Valhall and Hod to 64.05% and 62.5%, respectively. In December, Hess joined with Royal Dutch Shell (RDS.A - Analyst Report) for a strategic asset swap deal. The deal had doubled Hess’ interest in these two fields to 56.2% and 50%, respectively.

The increasing stake in the offshore Norway fields has a favorable impact on Hess. This will support Hess’ long-term objective of profitably increasing its reserves and production.

The company’s improving fundamentals, commodity price leverage and exposure to areas with high resource potential (such as Brazil, Ghana, Indonesia and offshore Australia) position the stock to outperform its peers. We continue to see upstream momentum on the back of the company's large inventory of exploration and development projects.

Management pointed out that the drilling moratorium on offshore Gulf of Mexico would have no material impact on the company’s operations considering that Hess currently has no exposure in this region. Hess is optimistic with its international operations. While the stake increase in the off-Norway fields is a notable development, the company’s plan to invest in the Paris Basin and Bakken shale play later this year will act as catalysts in the near to medium term, in our view.

Get the full analysis of all these stocks by going to http://at.zacks.com/?id=5507.

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.

About the Analyst Blog

Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=7159.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5509.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com

 

Read the full analyst report on NBIX

Read the full analyst report on IBKR

Read the full analyst report on HES

Read the full analyst report on TOT

Read the full analyst report on BP

Read the full analyst report on RDS.A

 

Please login to Zacks.com or register to post a comment.



Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
7 Best Stocks for the Next 30 Days
Get your free Welcome Gifts today*:
 1.  Special Report with best short-term Zacks recommendations from the list that averages a gain of +26% per year
 2.  Our free e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 26, 2012 05:57 am ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center